An evaluation of glucose tolerance in essential hypertension

Yonsei Medical Journal

Volumn 50, Issue 2, 2009, Pages 195-199

  Tugrul, Armagan ^a,b   Guldiken, Sibel ^a   Ugur Altun, Betul ^a   Arikan, Ender ^a  

^a TRAKYA UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Diabetes mellitus; Epidemiology; Glucose tolerance; Hypertension; Insulin resistance

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE DURATION; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MICROANGIOPATHY; ORAL GLUCOSE TOLERANCE TEST; PREVALENCE; RISK ASSESSMENT; SEX DIFFERENCE;

AGED; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE INTOLERANCE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED;

EID: 66549129439     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2009.50.2.195     Document Type: Article

References (28)

1. Pereira MA, Jacobs DR Jr, Van Horn L, Slattery ML, Kartashov AI, Ludwig DS. Dairy comsumption, obesity, and the insulin resistance syndrome in young adults: the CARDIA Study. JAMA 2002;287: 2081-9.
2. Natalucci S, Boemi M, Fumelli P, Testa I, Fumelli D, Burattini R. One- and two-compartment minimal models detect similar alterations of glucose metabolism indexes in hypertension. Metabolism 2000;49: 1529-36.
3. Gouveia LM, Paccola GM, Torquato MT, Menezes FO, Piccinato CE, Foss MC. Peripheral glucose metabolism in patients with essential hypertension. Horm Metab Res 2000;32: 35-9.
4. American Diabetes Association. Screening for type 2 diabetes. Diabetes Care 2002; 25 (Suppl 1):S21-4.
5. von Eckardstein A, Schulte H, Assmann G. Risk for diabetes mellitus in middle-aged Caucasian male participants of the PROCAM study: implications for the definition of impaired fasting glucose by the American Diabetes Association. Prospective cardiovascular Münster. J Clin Endocrinol Metab 2000;85:3101-8.
6. Dunstan DW, Zimmet PZ, Welborn TA, De Courten MP, Cameron AJ, Sicree RA, et al. The rising prevalence of diabetes and impaired glucose tolerance: the Australian Diabetes, Obesity and Lifestyle Study. Diabetes Care 2002;25:829-34.
7. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403.
8. Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343-50.
9. Barzilay JI, Spiekerman CF, Kuller LH, Burke GL, Bittner V, Gottdiener JS, et al. Prevalence of clinical and isolated subclinical cardiovascular disease in older adults with glucose disorders: the Cardiovascular Health Study. Diabetes Care 2001;24:1233-9.
10. Rodriguez BL, Abbott RD, Fujimoto W, Waitzfelder B, Chen R, Masaki K, et al. The American Diabetes Association and World Health Organization classifications for diabetes: their impact on diabetes prevalence and total and cardiovascular disease mortality in elderly Japanese-American men. Diabetes Care 2002;25:951-5.
11. Lim SC, Tai ES, Tan BY, Chew SK, Tan CE. Cardiovascular risk profile in individuals with borderline glycemia: the effect of the 1997 American Diabetes Association diagnostic criteria and the 1998 World Health Organization Provisional Report. Diabetes Care 2000;23:278-82.
12. Shaw JE, Zimmet PZ, Hodge AM, de Courten M, Dowse GK, Chitson P, et al. Impaired fasting glucose: how low should it go? Diabetes Care 2000;23:34-9.
13. Borde-Perry WC, Campbell KL, Murtaugh KH, Gidding S, Falkner B. The association between hypertension and other cardiovascular risk factors in young adult African Americans. J Clin Hypertens (Greenwich) 2002;4:17-22.
14. Simon NR, Frishman WH. Diabetes mellitus in the aging: epidemiologic and therapeutic considerations. Am J Geriatr Cardiol 1992;1:22-36.
15. King H, Djumaeva S, Abdullaev B, Gacic Dobo M. Epidemiology of glucose intolerance and associated factors in Uzbekistan: a survey in Sirdaria province. Diabetes Res Clin Pract 2002;55:19-27.
16. Lam TH, Liu LJ, Janus ED, Lam KS, Hedley AJ; Hong Kong Cardiovascular Risk Factor Prevalence Study Steering Committee. Fibrinogen, other cardiovascular risk factors and diabetes mellitus in Hong Kong: a community with high prevalence of type 2 diabetes mellitus and impaired glucose tolerance. Diabet Med 2000;17:798-806.
17. Hanefeld M, Koehler C, Henkel E, Fuecker K, Schaper F, Temelkova-Kurktschiev T. Post-challenge hyperglycaemia relates more strongly than fasting hyperglycaemia with carotid intima-media thickness: the RIAD Study. Risk Factors in Impaired Glucose Tolerance for Atherosclerosis and Diabetes. Diabet Med 2000;17:835-40.
18. Ribstein J, Du Cailar G, Mimran A. Glucose tolerance and age-associated dacline in renal function of hypertensive patients. J Hypertens 2001;19:2257-64.
19. Satman I, Yilmaz T, Sengül A, Salman S, Salman F, Uygur S, et al. Population-based study of diabetes and risk characteristics in Turkey: results of the turkish diabetes epidemiology study (TURDEP). Diabetes Care 2002;25:1551-6.
20. Ozkan Y, Donder E, Dogan H, Demir A, YalnIz M, Sokmen S. Hipertansif hastalarda tip 2 diabetes mellitus ve bozulmus glukoz tolerans sIklIgI. Turkish Journal of Endocrinology and Metabolism 1999;3(2 Suppl 1):129.
21. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2002;25(Suppl 1):S5-20.
22. Ribstein J, Du Cailar G, Mimran A. Glucose tolerance and age-associated decline in renal function of hypertensive patients. J Hypertens 2001;19:2257-64.
23. Sinha R, Fisch G, Teague B, Tamborlane WV, Banyas B, Allen K, et al. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 2002;346:802-10.
24. Tomiyama H, Kimura Y, Okazaki R, Kushiro T, Abe M, Kuwabara Y, et al. Close relationship of abnormal glucose tolerance with endotheliel dysfunction in hypertension. Hypertension 2000;36:245-9.
25. Gabir MM, Hanson RL, Dabelea D, Imperatore G, Roumain J, Bennett PH, et al. Plasma glucose and prediction of microvascular disease and mortality: evaluation of 1997 American Diabetes Association and 1999 World Health Organization criteria for diagnosis of diabetes. Diabetes Care 2000;23:1113-8.
26. Meigs JB, D'Agostinsr RB, Nathan DM, Rifai N, Wilson PW; Framingham Offspring Study. Longitudinal association of glycemia and microalbuminuria; the Framingham Offspring Study. Diabetes Care 2002;25:977-83.
27. Sosenko JM, Hu D, Welty T, Howard BV, Lee E, Robbins DC. Albuminuria in recent-onset type 2 diabetes. Diabetes Care 2002;25: 1078-84.
28. Isomaa B, Almgren P, Tuomi T, Forsén B, Lahti K, Nissén M, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001;24:683-9.